Bharath Srinivasan
@bharath_igc
Mechanistic Enzymologist. Principal Scientist AstraZeneca.Marie-Curie IF. Editor@COPHAR, BJP, FEBS J. Faculty@F1000. Asso.Prof. RGU. Views expressed are mine.
ID: 794696341
31-08-2012 21:17:02
1,1K Tweet
261 Followers
345 Following
Thanks for coming. I really look forward to meeting you again Adrian Mulholland
Excited to share a perspective I wrote on the evolving role of irreversible inhibitors in drug discovery published in the JMedChem. I would specifically like to thank Henry Blackwell for his immense contribution. Cancer Research UK , ACS Publications Bio & Med Chem Content
Entabolons: How Metabolites Modify the Biochemical Function of Proteins and Cause the Correlated Behavior of Proteins in Pathways pubs.acs.org/doi/10.1021/ac… Bharath Srinivasan Brice Edelman #JCIM Vol65 Issue11 #Bioinformatics
Covalent inhibitors are characterized by a ratio of two constants. Bharath Srinivasan explains that considering both, and how one affects the other, could help advance hits on difficult targets: practicalfragments.blogspot.com/2025/07/the-im… JMedChem Cancer Research UK ACS Publications Bio & Med Chem Content
"Resolving Enzyme–Substrate–Activator Ambiguity: A Minimalist Enzyme Kinetic Framework for PROTAC Design and Optimization" pubs.acs.org/doi/10.1021/ac… JMedChem ACS Publications, Science and Innovation at Cancer Research UK Cancer Research UK #PROTAC, #MolecularGlues, #ScienceOfPROTAC, #TargetedProteinDegradation